Skip to content

Clinical trials

Phase 1/2 Pancreatic Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 1/2 Country / region: Germany Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20032
20071
20091
20113
20162
20174
20202
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting3
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Bristol-Myers Squibb2
Novartis Pharmaceuticals2
AmMax Bio, Inc.1
AstraZeneca1
Bayer1
Bold Therapeutics, Inc.1
CONKO-Studiengruppe1
EMD Serono Research & Development Institute, Inc.1
FeRx1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms20
Colorectal Neoplasms6
Carcinoma, Non-Small-Cell Lung4
Neoplasm Metastasis4
Stomach Neoplasms4
Melanoma3
Breast Neoplasms2
Cholangiocarcinoma2
Colonic Neoplasms2
Endometrial Neoplasms2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.